Sikkerhed og effekt af Revatio ved samtidig anvendelse af andre PDE5- hæmmere er ikke undersøgt hos patienter med pulmonal arteriel hypertension.
The safety and efficacy of Revatio when co-administered with other PDE5 inhibitors has not been studied in pulmonary arterial hypertension patients.